Skip to main content
Premium Trial:

Request an Annual Quote

Genomtec Gets CE-IVD Mark for Saliva-Based Molecular SARS-CoV-2 Test

NEW YORK — Polish diagnostics firm Genomtec said on Monday that it has received CE-IVD marking for its saliva-based SARS-Cov-2 EvaGreen Direct-RT-LAMP Kit.

According to Genomtec, based in Wroclaw, the test is designed to detect the SARS-CoV-2 S and N genes in saliva samples. It does not require nucleic acid purification and can provide results in several minutes. The test is currently offered through Dolnośląskie Centrum Medyczne in Wroclaw, a reference lab for Genomtec's products. It is compatible with standard RT-PCR instrumentation, the company added.

"By elimination of the laboratory nucleic acid purification stage from biological material, we have shortened the processing time and simplified the entire diagnostic process, which also reduces its cost of labor," Miron Tokarski, Genomtec's cofounder and president, said in a statement. "Our new genetic tests from saliva will be able to increase the laboratories' diagnostic throughput by several times."

Genomtec has also been developing a new testing platform, to be launched later this year. In 2019, the company received a $2.4 million grant from Poland's National Center for Research and Development to support its development of a handheld molecular diagnostic testing device and accompanying respiratory disease panel.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.